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Objectives: We aimed to determine the seroprevalence of Crimean-Congo hemorrhagic fever virus
(CCHFV) infection in Yunnan Province, China.
Materials and methods: One thousand six hundred and ﬁfty-seven human serum samples and 1280 ticks
(Hyalomma asiaticum) were collected from ﬁve counties (Menglian, Menghai, Lancang, Mengla, and
Ximeng). Serum samples were analyzed independently by indirect immunoﬂuorescence assay and
Western blotting to detected CCHFV antibody. The ticks were examined by reverse transcriptase-
polymerase chain reaction (RT-PCR) to detect virus RNA.
Results: The CCHFV IgG positivity was 3.4% (57/1657). A multivariate analysis was performed, and
variables that increased the chance of infection were found to include history of tick bite or contact (odds
ratio (OR) 16.6, 95% conﬁdence interval (CI) 7.5–37.0) and age > 30 years (OR 6.8, 95% CI 1.6–28.2). The
RT-PCR positive rate for ticks was 14.3% (6/42).
Conclusions: The ﬁve counties (Menglian, Menghai, Lancang, Mengla, and Ximeng) in Yunnan are areas
with the potential for CCHF outbreaks. Residents should protect themselves against tick bites and the
surveillance of CCHFV in this region should be improved.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne
disease that may affect humans. The causative agent, Crimean-
Congo hemorrhagic fever virus (CCHFV), is distributed worldwide
and has been found in more than 31 countries across Africa, Asia,
southeast Europe, and the Middle East. The occurrence of CCHF is
seasonal and regional, usually peaks between March and June, and
the general population appears to be susceptible to this infection.
Humans become infected mostly by the bites of ticks (Hyalomma
spp). However, humans can also be infected by contact with a
patient with CCHF during the acute phase of infection, or by
contact with blood or tissue from viremic livestock. The mortality
rate of this disease has been reported to range between 10% and
30%.1–4* Corresponding authors. Tel.: +86 27 87198465; fax: +86 27 87198465.
E-mail addresses: kouzheng@wh.iov.cn (Z. Kou), Litx@wh.iov.cn (T. Li).
1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.03.013In China, CCHF was ﬁrst recorded in southern Xinjiang in 1965,
with sporadic cases of death. CCHFV-positive serum samples were
identiﬁed subsequently in humans and livestock in several
provinces, including Qinghai, Yunnan, and Hainan provinces.5–7
Yunnan is located in southwestern China and has a large area of
tropical forest and high levels of biodiversity. The ﬁrst CCHFV human
infection in Yunnan was recorded in Dali County in 1982, and
subsequent epidemiological surveys detected CCHFV antibody-
positive sera in the local residents and livestock (goats, cattle, yaks) in
the southwestern region of this province, including Xishuangbanna,
Tengchong, Jinghong, Yingjiang, Lushui, Linchang and Menglian.8–12
In 2008, we surveyed the status of CCHFV human infection in
ﬁve counties (Menglian, Menghai, Lancang, Mengla, and Ximeng)
of southwestern Yunnan. One thousand six hundred and ﬁfty-
seven human serum samples were collected and tested for CCHFV
antibody (CCHFV-IgG) by indirect immunoﬂuorescence assay
(IIFA) and Western blotting.13–21 In addition, 1280 hard ticks
were collected from the local livestock in these ﬁve counties and
analyzed by RT-PCR. We studied the seroprevalence of CCHFVses. Published by Elsevier Ltd. All rights reserved.
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associated with CCHFV infection.
2. Methods
2.1. Study sites and participants
CCHFV antibody-positive cases have been reported from the
counties of Menglian, Menghai, Lancang, Mengla, and Ximeng, or
from near these regions. Hence these counties were selected as
sample collecting points (Figure 1). The study was carried out
between April and June 2008.
Participants were those undergoing regular physical exam-
inations or medical treatment at local Chinese Center for Disease
Control and Prevention facilities. Those who met the following
criteria were selected as study subjects: (1) age over 5 years, (2)
resident in one of the ﬁve counties, (3) could provide verbal or
written informed consent. Based on the method of simple
random sampling, 1657 individuals were included in this
investigation.
2.2. Data collection
A questionnaire was completed by each participant. The
questionnaire included questions on ethnicity, gender, age,
residence, and the history of tick bite or contact. Participants
were also asked to provide blood samples. During our survey,
non-response participants (1.4%, 24/1657) were randomly
replaced by others in the same region. The ﬁnal number of
responding participants was kept at 1657 (1211 from rural areas
and 446 from urban areas; 694 from Menglian, 108 from
Menghai, 495 from Lancang, 73 from Mengla, and 287 from
Ximeng); 11 locations in the ﬁve counties were included (ﬁve
urban and six rural).
In addition, 1280 ticks (Hyalomma asiaticum) were also
collected from local goats and cattle in the ﬁve counties.Figure 1. Locations for sample collection in southwestern Yunnan, 2008. Upper right ind
China.2.3. CCHFV-IgG antibody detection in human serum
The serum samples collected in our survey were analyzed for the
presence of CCHFV-IgG by two methods, IIFA and Western blotting.
Known CCHFV-IgG-positive and negative human serum samples
(kindly provided by the Center for Disease Control and Prevention of
Xinjiang Uygur Autonomous Region) were used as controls.7
For the IIFA, Vero E6 cells infected with CCHFV (Chinese strain
YL04057) were cultured for 4 days and then harvested by
trypsinization and washed with phosphate-buffered saline
(PBS).13 The cells were spotted onto 14-well HT-coated glass
slides and ﬁxed with acetone at room temperature for 5 min.13
CCHFV IIFA antigen slides were stored at 80 8C until use.
Serum samples were diluted with PBS to 1:50 and 1:100. The
diluted samples were placed on CCHFV slides and incubated under
humidiﬁed conditions at 37 8C for 1 h. After this the slides were
washed three times with 0.01 M PBS (pH 7.4); ﬂuorescein
isothiocyanate (FITC)-conjugated goat anti-human IgG antibody
was then added (200 ml/well) and the slides incubated at 30 8C for
30 min and rinsed (3  3 min) with PBS to remove excess secondary
antibody. The ﬂuorescein isothiocyanate signal was then observed
under a ﬂuorescence microscope (Leica Microsystems, Germany).13–
15,19,20 Positive and negative control human sera were also tested
under the same conditions in each IIFA test for veriﬁcation.
For the Western blotting, primers (NP1: 50-CCGGATCCATGGA-
GAACAAAATCGAGGTGA-30, NP2: 50-CCGAAT TCTCAGAT-
GATGTTGGCACTGGTGGCG-30) were synthesized according to the
sequence of strain YL04057 (GenBank FJ562093).The complete
open reading frame (ORF) of the CCHFV S gene was ampliﬁed from
the cDNA of the strain YL04057 and then ligated to the pET-32a(+)
vector to construct the expression plasmid pET-32a(+)/CCHFV S.
The fusion proteins were expressed in Escherichia coli (BL21).
Puriﬁcation of CCHFV nucleocapsid protein (NP) was performed
according to the instructions included with the Ni-NTA Puriﬁcation
System (Qiagen, Germany). The eluted protein was analyzed by
12% sodium dodecyl sulfate polyacrylamide gel electrophoresisicates the locations of Xinjiang, Qinghai and Yunnan, the CCHFV epidemic areas of
Table 1
Socio-demographic characteristics of study population
Characteristic (N = 1657)
n %
Gender
Male 822 49.6
Female 835 50.4
Ethnicity
Han 926 55.9
Minority 731 44.1
Age groups (years)
5–20 144 8.7
21–30 273 16.5
31–40 317 19.1
41–50 356 21.5
51–60 357 21.5
61–70 210 12.7
County
Menglian 694 41.9
Menghai 108 6.5
Lancang 495 29.9
Mengla 73 4.4
Ximeng 287 17.3
Location of residence
Rural 1211 73.1
Urban 446 26.9
Occupation
Not declared 50 3.0
Farmer (planting rice, tea, etc.) 318 19.2
Herdsman 630 38.0
Small handicraftsman 213 12.9
Homemaker 63 3.8
Factory worker 102 6.2
Government ofﬁcial 146 8.8
Student 114 6.9
Child 21 1.3
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staining.16
Puriﬁed recombinant CCHFV NP (rNP) proteins were used in
Western blotting of the tested human serum samples. The rNP
proteins were adjusted to 1  SDS sample buffer (0.0625 M Tris
(pH 6.8), 2% SDS, 10% glycerol, 5% b-mercaptoethanol, 0.001%
bromophenol blue) and boiled for 10 min. Equal quantities of
samples were loaded onto a 12% SDS-PAGE gel. The protein bands
were then electroblotted onto a nitrocellulose membrane. The
blots were incubated in PBS containing 0.05% Tween-20 (TPBS) and
5% skim milk (M-TPBS) at room temperature for 1 h to block non-
speciﬁc sites. The blots were incubated with human sera (1:100
dilution) for 1 h at room temperature. After being washed in TPBS,
the membranes were incubated with secondary antibodies
(horseradish peroxidase (HRPO)-conjugated goat anti-human
IgG antibody (1:2000 dilution)).16–19,21 Positive and negative
control human sera were also tested under the same conditions in
each Western blotting test for veriﬁcation.
2.4. Investigation of CCHFV from hard ticks
One thousand two hundred and eighty ticks were grouped into
42 pools according to the location of collection. Each pool contained
18–30 ticks and was rinsed three times with PBS (pH 7.4), cut into
small pieces, ground into a 10% tissue suspension and centrifuged
(4 8C, 3000 rpm, 30 min). The supernatant was transferred into two
tubes (200–300 ml/tube). One tube was used for testing CCHFV RNA
and the other tube was stored at 80 8C for virus isolation.7,22–24
Total RNA from ticks was extracted by TRIzol reagent
(Invitrogen Life Technologies, USA). The One-Step RNA PCR Kit
(AMV; TaKaRa, Japan) was used for the reverse transcriptase-
polymerase chain reaction (RT-PCR). Speciﬁc primer PCM-Tag (50-
CCGAGAATAAAATCGAGGTGAATCTCAAAGAAAT-30) and random
primers were used to amplify the cDNA. The primers for the
PCR assay were targeted to the CCHFV S segment: S1F (50-
TGGACACTTTCACAAACTC-30, 135–153 bp) and S1R (50-
GACAAATTCCCTGCACCA-30, 653–670 bp) were used for the ﬁrst
round (expected product size was 536 bp) of the nested PCR, while
S2F (50-GAGTGTGCCTGGGTTAGTTC-30, 290–309 bp) and S2R (50-
GACATTACAATTTCACCAGG-30, 530–549 bp) were used for the
second round (expected product size was 260 bp).7,22 According to
the recommended protocol, 1 mg of total RNA was added in 50 ml
reaction mixture with a temperature proﬁle of 50 8C for 30 min
(reverse transcription step), 94 8C for 2 min, followed by 35 cycles
at 94 8C for 30 s, 45 8C for 30 s, 72 8C for 35 s. Products were
analyzed by electrophoresis on a 1.5% agarose gel.
2.5. Virus isolation and identiﬁcation
The tick supernatant (20 ml) acquired in the previous step was
inoculated into the brain of a new born suckling mouse (Kunming
white mice). The samples that caused typical symptoms at 5–9
days post-inoculation for at least two passages in suckling mice
were regarded as pathogenic. The typical symptoms of the suckling
mice included becoming sensitive to stimuli, becoming easily
startled, having an arched back, losing balance, and refusing to be
nursed. After two to four blind passages in the brains of suckling
mice, the brain tissues were tested by PCR for partial sequencing of
CCHFV S segments as above.7,23
All manipulations with infectious material were performed in
our biosafety level 3 facilities.
2.6. Statistical analyses
Statistical analyses were performed using SPSS 13.0 package
program (IBM SPSS, Chicago, IL, USA). For univariate analysis,frequencies and medians of variables and measures were
calculated. Relationships between possible risk factors and CCHFV
infection were analyzed using univariate logistic regression and
estimating odds ratios (OR) with 95% conﬁdence intervals (CI).
Variables signiﬁcant in the univariate analysis (p < 0.05) were
included in the multivariate logistic regression analysis. In
multivariate logistic regression, the backward (logistic regression)
elimination procedure was used to select a model.
3. Results
3.1. Demographics of the study population
The average age of the 1657 participants was 42.0 years
(standard deviation 15.4). The male to female ration was 1:1.02. Of
the participants included in the study, 73.1% (1211/1657) were
from rural areas and 26.9% (446/1657) from urban areas; 41.9%
(694/1657) of samples were collected from Menglian, 6.5% (108/
1657) from Menghai, 29.9% (495/1657) from Lancang, 4.4% (73/
1657) from Mengla, and 17.3% (287/1657) from Ximeng. The
majority of participants were herdsmen (38.0%), followed by
farmers (19.2%) growing tea or planting other crops, small
handicraftsmen (12.9%), government ofﬁcials (8.8%), students
(6.9%), factory workers (6.2%), homemaker (3.8%), those whose
occupation was not declared (3.0%), and children (1.3%) (Table 1).
3.2. CCHFV prevalence and possible related risk factors
Of the 1657 serum samples, 60 were identiﬁed by IIFA as
CCHFV-positive, and 57 were identiﬁed as positive by Western
blotting (all included in the IIFA-positives). The prevalence of
CCHFV in Yunnan Province was 3.4% (57/1657). As shown in Table
2, there was no obvious difference in the prevalence between
Table 2
Risk factors for CCHFV infection in persons living in southwestern of Yunnan
Variable Positive/total No. (%) OR (95% CI) p-Value AOR (95% CI) p-Value
Gender
Male 29/822 (3.5) 1.1 (0.6–1.8) 0.845
Female 28/835 (3.4) 1.0
Ethnicity
Han 30/926 (3.2) 0.9 (0.5–1.5) 0.615
Minority 27/731 (3.7) 1.0
Age (years)
>30 55/1240 (4.4) 9.6 (2.3–39.7) 0.002 6.8 (1.6–28.2) 0.009
30 2/417 (0.5) 1.0
Location of residencea
Rural 55/1211 (4.5) 10.6 (2.6–43.5) 0.001
Urban 2/446 (0.5) 1.0
Tick-bite or tick contact
Yes 50/494 (10.1) 18.6 (8.4–41.3) 0.000 16.6 (7.5–37.0) 0.000
No 7/1163 (0.6) 1.0
OR, odds ratio; AOR, adjusted odds ratio; CI, conﬁdence interval.
a This variable was eliminated from the model in multivariate analysis.
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minority ethnicities was also similar (3.2% vs. 3.7%). The positives
were relatively common among the participants living in rural
areas (4.5%, 55/1211), in the actively working age group (>30
years; 4.4%, 55/1240), and in those with a history of tick bite or
contact (10.1%, 50/494).
Of the 57 positive samples, almost all were from Menglian
(63.2%, 36/57) and Lancang (33.3%, 19/57). Only 3.5% (2/57) were
from Ximeng and no positive sample was from Menghai or Mengla.
The proportion of positive samples was high for herdsmen (56.1%,
32/57) and farmers (22.8%, 13/57), while low for homemakers
(8.8%, 5/57), small handicraftsmen (7.0%, 4/57), those whose
occupation was not declared (3.5%, 2/57), and factory workers
(1.8%, 1/57). There was no positive sample from a government
ofﬁcial, student, or child.
Through univariate analysis, age >30 years (OR 9.6, 95% CI 2.3–
39.7), living in rural area (OR 10.6, 95% CI 2.6–43.5), and history of
tick bite or contact (OR 18.6, 95% CI 8.4–41.3) were the risk factors
for CCHFV infection. In multivariate analysis, age >30 years (OR
6.8, 95% CI 1.6–28.2) and tick-bite or tick contact (OR 16.6, 95% CI
7.5–37.0) were signiﬁcant for infection. However, the variable
‘location of residence’, which had a signiﬁcant relationship with
infection in the univariate analysis, was eliminated from the model
(Table 2).
3.3. Virus detection and isolation
Six tick (H. asiaticum) pools (Nayun, Jingxin, Laba, Mengma,
Fuyan, Donghui) were positive for the partial CCHFV S gene using
the RT-PCR method. The percentage of positive tick pools was
14.3% (6/42). Samples from these six pools were inoculated into
the brains of newborn mice. No mice demonstrated typical
symptoms of CCHFV after inoculation and no virus was isolated.
4. Discussion
Following the ﬁrst recording of CCHFV human infection in
Yunnan Province in 1982, subsequent studies on seroprevalence of
CCHFV were conducted in different areas of this province,
including Tengchong, Jinghong, and Menglian. Between 1988
and 1999, a survey of CCHFV antibody was conducted in 10 areas of
southwestern Yunnan.11 One thousand eight hundred and thirteen
serum samples were collected from healthy individuals and
patients with fever of unknown origin. The results showed that
populations with a high prevalence of CCHFV-IgG were concen-
trated in Xishuangbanna and Menglian. According to the results ofour survey, it appears that the possibility of an epidemic of CCHFV
still exists in Yunnan Province. All ﬁve of the counties (Menglian,
Menghai, Lancang, Mengla, and Ximeng) in our survey are located
in southwestern Yunnan and have a typical subtropical climate,
with mountains and rivers and a widely distributed rich diversity
of wild animal and tick species. The results of our study show that
the most important risk factors for CCHFV infection are a history of
tick bite and being aged >30 years, results similar to those reported
previously (contact with ticks or tick bite, close contact with
animals, handling and slaughtering viremic domestic animals, and
being aged >40 years).4,25–27
Although the factor ‘living in a rural area’ was excluded in the
multivariate analysis (Table 2), it cannot be ignored. In southwest-
ern Yunnan, most rural residents depend on goats or cattle for
nutrition and their economic livelihood, and some residents even
share their houses with the livestock. These life habits may
increase the risk of CCHFV infection through close contact with the
viremic tissues of livestock or through tick bites. Growing tea is
also a major economic activity for the rural residents. When
farmers are working on the tea plantations, the chance of infection
with CCHFV through tick bite may be increased. However, the
infection risk may be low among the urban residents in Yunnan,
since very few of them engage in agriculture or animal husbandry-
related activities, and the urban living environment is not suitable
for tick survival. Furthermore, of those who were CCHFV antibody-
positive, most were herdsmen (56.1%), followed by farmers
(22.8%). So herdsmen and farmers may be the groups at risk of
CCHFV infection.
Tick pools from six locations (Nayun, Jingxin, Mengma, Fuyan,
Laba, Donghui) were positive by RT-PCR, indicating that these
samples contained CCHFV. Four of the six locations (Nayun,
Jingxin, Mengma and Fuyan) are in Menglian County and two (Laba
and Donghui) in Lancang County. Moreover, most of the positive
human serum samples were also from Menglian (63.2%) and
Lancang (33.3%). It is suggested that the public health conditions
should be improved and the surveillance of CCHFV should be
strengthened in these two counties.
Acknowledgements
We thank the staff of the local CDC of Yunnan Province for
excellent assistance during the survey. We also thank all
participants in the survey for their support and for sharing their
information.
This work was supported by the Ministry of Science
and Technology of China (2010CB534005, 2007FY210700,
H. Xia et al. / International Journal of Infectious Diseases 15 (2011) e459–e463 e4632009ZX10004-109), the National R&D Infrastructure and Facility
Development Program of China (BSDN2009-10, BSDN2009-18),
the National Natural Science Foundation of China (30970024,
30900060), and the Chinese Academy of Sciences (KSCX2-YW-N-
065, KSCX2-YW-R-157, 158 and 159, INFO-115-C01-SDB3-01,
INFO-115-C01-SDB4-21, IN-FO-115-D02, IN-FO-115-C01-SDB2-
02).
This research was approved by the Review Board of the Wuhan
Institute of Virology, the Chinese Academy of Sciences, and
subjects gave informed consent to the work.
Conﬂict of interest: No conﬂict of interest to declare.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ijid.2011.03.013.
References
1. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic
fever in Asia, Europe, and Africa. J Med Entomol 1979;15:307–417.
2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004;64:145–60.
3. Flick R, Whitehouse CA. Crimean-Congo hemorrhagic fever virus. Curr Mol Med
2005;5:753–60.
4. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203–14.
5. Tang Q. Advances in Crimean-Congo hemorrhagic fever. Chin Exp Clin Virol
2006;20:86–9.
6. Tang Q, Prehaud C, Bouloy M, Feng CH, Zhao XQ, Chen HX, Yang WS. Sequencing
and analysis of S gene segment of Crimean-Congo hemorrhagic fever virus. J
Microbiol Immunol 1999;19:461–5.
7. Sun SR, Dai X, Aishan M, Wang XH, Meng WW, Feng CH, et al. Epidemiology and
phylogenetic analysis of the Crimean-Congo hemorrhagic fever viruses in
Xinjiang. China J Clin Microbiol 2009;47:2536–43.
8. Jing Q, Liang J. Investigative situation of Crimean-Congo hemorrhagic fever
virus. World J Infect 2008;8:460–3.
9. Tang Q. Research evolved of Crimean-Congo hemorrhagic fever virus. Chinese J
Exp Clin Viral 2006;20:86–9.
10. Wang Z. A case report of Crimean-Congo hemorrhagic fever virus infected,
Yunnan. Kunming Hospital Medicine Information Compile 1984;116:8.
11. Hou ZL, Huang WL, Zi DY, Zhang HL, Shi HF, Gong ZD, Lei YM. Study on
serological epidemiology of tick-borne viruses in Yunnan. Chin J Vector Biol
Control 1992;3:173–6.12. Liu H, Huang W, Zi D. Serologic survey of tick-borne virus in Yunnan. Chin J
Vector Biol Control 1997;3:173–6.
13. Masayuki S, Tang Q, Masahiro N, Akihiko M, Tetsuro I, Christophe P, et al.
Immunoﬂuorescence technique using HeLa cells expressing recombinant nu-
cleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo
hemorrhagic fever virus. J Clin Microbiol 2002;40:372–5.
14. Wang XH, Feng CH, Meng WW, Azat M. Crimean-Congo hemorrhagic fever
virus detected by immunoﬂuorescent test. Chin J Epidemiol 2006;25:
641–2.
15. Ahmed AA, McFalls JM, Hoffmann C, Filone CM, Stewart SM, Paragas J, et al.
Presence of broadly reactive and group-speciﬁc neutralizing epitopes on newly
described isolates of Crimean-Congo hemorrhagic fever virus. J Gen Virol
2005;86:3327–36.
16. Wei PF, Luo YJ, Li TX, Wang HL, Hu ZH, Zhang FC, et al. Serial expression of the
truncated fragments of the nucleocapsid protein of CCHFV and identiﬁcation of
the epitope region. Virol Sin 2010;25:45–51.
17. Ma BJ, Hang CS, Xie YX, Wang SW. Sequencing, expression and diagnostic
application of the nucleoprotein gene of Xinjiang hemorrhagic fever virus. J
Microbiol Immunol 2004;2:29–34.
18. Saijo M, Qing T, Niikura M, Maeda A, Ikegami T, Prehaud C, et al. Recombinant
nucleoprotein-based enzyme-linked immunosorbent assay for detection of
immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J
Clin Microbiol 2002;40:1587–91.
19. Feng Z. Detection method of Crimean-Congo hemorrhagic fever virus. Endemic
Dis Bull 2004;19:101–13.
20. Liu L, Qian Y, Zhu R, Zhao L, Deng J. Generation of recombinant nucleocapsid
protein of human metapneumovirus in baculovirus for detecting antibodies in
the Beijing population. Arch Virol 2010;155:47–54.
21. Burt FJ, Swanepoel R, Braack LE. Enzyme-linked immunosorbent assays for the
detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of
livestock and wild vertebrates. Epidemiol Infect 1993;111:547–57.
22. Rodriguez LL, Maupin GO, Ksiazek TG, Rollin PE, Khan AS, Schwarz TF, et al.
Molecular investigation of a multisource outbreak of Crimean-Congo hem-
orrhagic fever in the United Arab Emirates. Am J Trop Med Hyg 1997;57:
512–8.
23. Saluzzo JF, Le Guenno B. Rapid diagnosis of human Crimean-Congo hemorrhag-
ic fever and detection of the virus in naturally infected ticks. J Clin Microbiol
1987;25:922–4.
24. Duh D, Saksida A, Petrovec M, Dedushaj I, Avsic-Zupanc T. Novel one-step real-
time RT-PCR assay for rapid and speciﬁc diagnosis of Crimean-Congo hemor-
rhagic fever encountered in the Balkans. J Virol Methods 2006;133:175–9.
25. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. The
epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J
Infect Dis 2009;13:380–6.
26. Izadi S, Naieni KH, Madjdzadeh SR, Nadim A. Crimean-Congo hemorrhagic fever
in Sistan and Baluchestan Province of Iran, a case-control study on epidemio-
logical characteristics. Int J Infect Dis 2004;8:299–306.
27. Ergonul O, Zeller H, Kilic¸ S, Kutlu S, Kutlu M, Cavusoglu S, et al. Zoonotic
infections among veterinarians in Turkey: Crimean-Congo hemorrhagic fever
and beyond. Int J Infect Dis 2006;10:465–9.
